NMPA Approval

Erythromycin Ethylsuccinate Granules

Approval Number

国药准字H51023174

Company成都迪康药业股份有限公司

Registration Date

November 18, 2020

Previous Approval Numbers

国药准字H51023174

Drug Information

Generic Name

琥乙红霉素颗粒

Dosage Form

颗粒剂

Strength

按C37H67NO13计算0.125g(12.5万单位)。

Drug Type

化学药品

Registration Date

November 18, 2020

Company Information

Applicant Company

Company Name成都迪康药业股份有限公司

Company Address

成都高新区（西区）迪康大道一号

Manufacturing Company

Company Name成都迪康药业股份有限公司

Company Address

成都高新区（西区）迪康大道一号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

琥乙红霉素颗粒 - NMPA 批准文号 | MedPath